Safety and Feasibility of Human Umbilical Cord Mesenchymal Stem Cell-Derived Secretome in the Treatment of Liver Cirrhosis: a Comprehensive Evaluation of Fibrosis Reduction, Immunomodulation, and Hepatic Regeneration: a Single Center, Randomized, Phase I Clinical Trial

NCT06629909 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
54
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Baermed

Collaborators